Mike Mensinger, Chief Product Officer at Beta Bionics, Inc. (BBNX), sold 13 shares at $17.00 ($221) on 2025-01-31, disclosed to the SEC on 2025-02-03.
Open-market sale of $221 BBNX by Chief Product Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BBNX | SELL | 2026-06-03 | $55K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $13K | — | Filing → |
| BBNX | SELL | 2026-01-07 | $66K | — | Filing → |